Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Participant-blinded Five-arm Crossover Study With Blinded Outcome Assessment Investigating Glucagon's Cardiovascular Effects With and Without Beta-blocker-induced Cardioinhibition.

NCT03533179 is registered in ClinicalTrials.gov with University Hospital Bispebjerg and Frederiksberg as lead sponsor.

NCT NCT03533179
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03533179 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Participant-blinded Five-arm Crossover Study With Blinded Outcome Assessment Investigating Glucagon's Cardiovascular Effects With and Without Beta-blocker-induced Cardioinhibition.
Lead sponsor
University Hospital Bispebjerg and Frederiksberg
Phase
Phase 4
Overall status
Completed
Start date
June 1, 2018
Completion date
October 1, 2019
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

drug overdose, overdose of beta-adrenergic blocking drug